IM Cannabis Expands Into Defense Tech With 51% Stake in Polish UAS…

Event summary

IM Cannabis Corp. signed a non-binding LOI to acquire 51% of Space Defense Innovations (SDI), a Polish UAS distributor, for a mix of shares, warrants, and a seller loan.
SDI distributes BlueBird Aero Systems' tactical UAS and hybrid VTOL-UAS platforms in Europe, with exclusivity in Poland.
IMCC gains a five-year call option to acquire the remaining 49% of SDI and will appoint a majority of SDI's board.
The deal includes a EUR 2.3 million convertible line of credit to SDI, with a minimum valuation of $5 million.
Closing is subject to due diligence, regulatory approvals, and definitive agreement negotiations within 60 days.

The big picture

IM Cannabis' move into defense technology marks a significant pivot from its core medical cannabis business, aligning with its stated goal of diversifying into tech-driven sectors. The acquisition of SDI provides IMCC with a foothold in Europe's tactical UAS market, where demand for advanced surveillance and reconnaissance systems is growing amid geopolitical tensions. The deal's structure—combining equity, debt, and a call option—reflects IMCC's cautious approach to expanding into a highly regulated industry.

What we're watching

Strategic Execution: Whether IM Cannabis can successfully integrate SDI while maintaining its core medical cannabis operations in Israel.
Regulatory Approvals: The pace at which SDI secures manufacturing licenses for BlueBird's UAS products in Europe.
Market Expansion: How IM Cannabis leverages SDI's exclusivity in Poland to expand into other European defense markets.